AstraZeneca Change in Accounts Receivable 2010-2025 | AZN
AstraZeneca change in accounts receivable for the twelve months ending June 30, 2025 was $-1.624B, a 13.96% increase year-over-year.
- AstraZeneca annual change in accounts receivable for 2024 was $-1.624B, a 13.96% increase from 2023.
- AstraZeneca annual change in accounts receivable for 2023 was $-1.425B, a 5.63% increase from 2022.
- AstraZeneca annual change in accounts receivable for 2022 was $-1.349B, a 40.37% increase from 2021.